Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New approach aims to save bladders while fighting aggressive cancer

NCT ID NCT07296705

Summary

This study is testing whether a combination of three drugs given before surgery can effectively treat HER2-positive muscle-invasive bladder cancer while allowing patients to keep their bladder. The treatment involves two targeted drugs plus chemotherapy, followed by maintenance therapy for those who respond well. The main goal is to see how many patients achieve complete tumor disappearance without needing complete bladder removal.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Putian University

    RECRUITING

    Putian, Fujian, 351106, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fujian Medical University Union Hospital

    RECRUITING

    Fuzhou, Fujian, 350001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fujian Provincial Hospital Affiliated to Fuzhou University

    RECRUITING

    Fuzhou, Fujian, 350001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangxi Cancer Hospital

    RECRUITING

    Nanchang, Jiangxi, 330029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Quanzhou First Hospital Affiliated to Fujian Medical University

    RECRUITING

    Quanzhou, Fujian, 362002, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sanming First Hospital

    RECRUITING

    Sanming, Fujian, 365099, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shandong Cancer Hospital

    RECRUITING

    Jinan, Shandong, 250117, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affi liated Hospital of Xiamen University

    RECRUITING

    Xiamen, Fujian, 361003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Wenzhou Medical University

    RECRUITING

    Wenzhou, Zhejiang, 325035, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhangzhou Affiliated Hospital to Fujian Medical University

    RECRUITING

    Zhangzhou, Fujian, 363000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, Zhejiang, 310005, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.